logo
ProjectPlanned

7-ACA Fermentation-Based Facility

The owner, status and timeline of this project. A free account opens every field.

Source: Manufacturing Today India

Orchid Pharma is establishing the country's first fermentation-based 7-Amino Cephalosporanic Acid (7-ACA) manufacturing facility in Kathua, Jammu and Kashmir. This facility will produce 7-ACA, a critical raw material for cephalosporin antibiotics, using biotechnology fermentation, reducing India's dependence on imports and supporting pharmaceutical self-reliance.

Status
Prospective
Sector
Chemical (Industrial), Manufacturing (Industrial)
Location
Kathua, Jammu and Kashmir, India
Updated
22 Jul 2026
Source
Manufacturing Today India

ConstructChat

Ask ConstructChat about 7-ACA Fermentation-Based Facility

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “7-ACA Fermentation-Based Facility” is an infrastructure initiative in the Chemical (Industrial) sector, located in Kathua, Jammu and Kashmir, India. Taiyo aggregates data on it from Manufacturing Today India.

Participants

Not available for this record.

Status

Original status

planned

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Orchid Pharma is establishing the country's first fermentation-based 7-Amino Cephalosporanic Acid (7-ACA) manufacturing facility in Kathua, Jammu and Kashmir. This facility will produce 7-ACA, a critical raw material for cephalosporin antibiotics, using biotechnology fermentation, reducing India's dependence on imports and supporting pharmaceutical self-reliance.

Original sector

Chemical & Pharmaceuticals

Budget

Location

Country

India

State

Jammu and Kashmir

City

Kathua

Source

Source

Manufacturing Today India

URL

More Details

Record type

Project

Sector

Chemical (Industrial), Manufacturing (Industrial)

Article published date

2026-03-22

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project